Price movement over the last 24 hours
Archi Indonesia Tbk vs Merck Tbk. — how do they compare? Archi Indonesia Tbk trades at Rp930 (market cap 24.86T, 21.8M 24h volume), while Merck Tbk. trades at Rp3,730 (market cap 1.65T, 60.4K 24h volume). The key difference: Archi Indonesia Tbk is far larger — about 15.1× Merck Tbk.'s market cap, and Archi Indonesia Tbk is more actively traded (21.8M versus 60.4K). Which is the better fit depends on your goals.
| ARCI | MERK | |
|---|---|---|
Market Cap | 24.86T | 1.65T |
Volume | 21.8M | 60.4K |
Lot | 218.04K | 604 |
Turnover | 20.81B | 223.42M |
Average Price | 954.51 | 3,698.92 |
Value | 20.81B | 223.42M |
Indicative Equilibrium Price | 930 | — |
Indicative Equilibrium Volume | 5.48K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Archi Indonesia Tbk. (the Company) was established based on Notarial Deed No. 1 of Fatma Agung Budiwijaya, S.H., dated September 14, 2010. The Company commenced its commercial operations in 2010 and is primarily involved in investment holding. PT Rajawali Corpora is the Companys parent and ultimate parent entity.
Read more on ARCI →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →